Here are six drug and medical device companies that made headlines in the past week.
1. Roche taps drug discovery firm to develop new antibiotic classes
Roche formed a strategic collaboration with the drug discovery company Warp Drive Bio to develop new classes of antibiotics.
2. Baxter expects temporary shortage of small saline IV bags
Baxter International anticipates a temporary shortage of small saline IV bags in the U.S. due to manufacturing issues in hurricane-damaged Puerto Rico.
3. Philips to suspend some defibrillator manufacturing in US: 5 things to know
Philips North America will suspend manufacturing and distribution of external defibrillators at facilities in Andover, Mass., and Bothell, Wash., with exceptions related to select automated external defibrillator models.
4. Pfizer contemplates sale, spinoff of consumer health unit
Pfizer may spin off or sell its consumer healthcare division, Pfizer Consumer Healthcare.
5. Gene therapy effective for blindness in short-term, says FDA
Spark Therapeutics' experimental gene therapy, Luxturna, improves vision in patients with a rare, inherited form of blindness, according to an initial review by Food and Drug Administration.
6. Medtronic, Mercy enter data sharing partnership to create more effective medical devices
Minneapolis-based Medtronic and Cincinnati-based Mercy are partnering to create a data sharing and analysis network that will gather clinical evidence for medical device innovation.
More articles on supply chain:
J&J's psoriasis drug OK'd for teens
FDA approves robotically-assisted surgical device
Baxter expects temporary shortage of small saline IV bags